| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.58M | - | |
| COO | 160.7K | $8.28M | -2,250 | |
| CFO | 104.4K | $5.37M | - | |
| Other | 76.0K | $3.91M | - | |
| VP | 29.4K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Wassil Jim53 | Chief Operating Officer | Sell | 2,250 | $56.83 | $127,869.75 | -1.4% | - | - | |
| Mar 17, 2026 | Cowan Elvia61 | SVP, Finance &CAO | Sell | 1,892 | $55.57 | $105,146.98 | -3.1% | - | - | |
| Mar 11, 2026 | Cowan Elvia61 | SVP, Finance &CAO | Sale+OE | 2,500 | $58.59 | $146,481.75 | -7.5% | - | - | |
| Mar 10, 2026 | Wassil Jim53 | Chief Operating Officer | Sell | 7,395 | $58.88 | $435,439.81 | -2.1% | - | - | |
| Dec 31, 2025 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 9,743 | $46.69 | $454,890.93 | -28.9% | +25.9% | - | |
| Dec 23, 2025 | Cowan Elvia61 | SVP, Finance | Sell | 11,623 | $47.92 | $556,971.85 | -24.5% | +17.0% | - | |
| Mar 5, 2025 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $70.74 | $353,699.01 | -3.8% | -53.1% | -21.3% | |
| Mar 3, 2025 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $73.27 | $586,165.11 | -2.5% | -51.4% | -17.0% | |
| Feb 18, 2025 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $83.85 | $670,822.74 | -3.5% | -61.2% | -31.9% | |
| Feb 5, 2025 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $90.07 | $450,368.64 | -3.2% | -67.3% | -39.7% |